Massachusetts General Hospital — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Massachusetts General Hospital appears in 908 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials908

Recruiting shown60

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar DepressionNCT07699445 · lead sponsor · 2026-09-09

Stress Management and Meditative Movements for Asian Americans With Depression and Physical SymptomsNCT07610928 · lead sponsor · 2026-09-01

A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and DiseasesNCT07780890 · lead sponsor · 2026-08-18

Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary DiseaseNCT07568509 · lead sponsor · 2026-08-17

PrEP4U: Assessing the Effectiveness of Integrated Same-Day Lenacapavir Initiation and Follow-up Choice on PrEP PersistenceNCT07335289 · lead sponsor · 2026-07-17

A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast CancerNCT07513311 · lead sponsor · 2026-07-07

BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer PreventionNCT07162337 · lead sponsor · 2026-06-18

LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol BNCT07600801 · lead sponsor · 2026-06-17

EXercise and Activin Inhibition to Modulate InflammatioN Effects on Heart Failure and Cognition (EXAMINE-HFC)NCT07202000 · lead sponsor · 2026-06-03

Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLCNCT07405190 · lead sponsor · 2026-05-01

Biomarker-based Trial of NPC-1 for Alzheimer's PathologyNCT07236190 · lead sponsor · 2026-04-01

Cardiac Effects of Mineralocorticoid Receptor Antagonism After PreeclampsiaNCT07238400 · lead sponsor · 2026-03-20

HIV Self-testing for Partners of HIV-uninfected Postpartum WomenNCT07194902 · lead sponsor · 2026-03-19

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject DrugsNCT07199335 · lead sponsor · 2026-02-24

Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal TumorsNCT07095517 · lead sponsor · 2026-02-24

Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis UseNCT06878859 · lead sponsor · 2026-02-23

A Prospective Longitudinal Observational Cohort Study of Pregnant Women Residing at High Altitude in BoliviaNCT07312227 · lead sponsor · 2026-02-11

A Digital Health Intervention to Improve Physical Function and Wellness of Lung Cancer SurvivorsNCT07227623 · lead sponsor · 2026-02-06

Changing Lives and Changing Outcomes-9 at Worcester Recovery Center and HospitalNCT07359157 · lead sponsor · 2026-02-05

Change My Story Task Shifted Mental Health InterventionNCT06389565 · lead sponsor · 2026-01-09

ActiveGirls: Physical Activity, Hormone Health, and Diabetes Risk in Early AdolescenceNCT07102797 · lead sponsor · 2025-11-24

Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist TreatmentNCT07226947 · lead sponsor · 2025-11-24

45th Multicenter Airway Research CollaborationNCT07166939 · lead sponsor · 2025-11-07

Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With ObesityNCT05933499 · lead sponsor · 2025-11-05

Spironolactone to Improve Pregnancy-Associated Hypertension TrajectoriesNCT07041281 · lead sponsor · 2025-10-16

Targeted Palliative Care Intervention for Patients With Metastatic Breast CancerNCT06795529 · lead sponsor · 2025-10-01

BRIDGE: Blood Pressure Reduction and Intervention Delivery Via Group EngagementNCT07091851 · lead sponsor · 2025-09-22

Comparing the Efficacy of Heated Yoga and Sauna as a Treatment for DepressionNCT07082998 · lead sponsor · 2025-09-12

Building ConnectionsNCT07091032 · lead sponsor · 2025-08-07

Mindfulness and Behavior Change to Improve Cardiovascular Health of Older People With HIVNCT06001814 · lead sponsor · 2025-07-21

Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIVNCT06554717 · lead sponsor · 2025-07-10

Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic ConditionsNCT06557005 · lead sponsor · 2025-05-23

Flotufolastat F 18 PET in Men With Very Low PSA RecurrenceNCT06862856 · lead sponsor · 2025-05-20

Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CTNCT06910956 · lead sponsor · 2025-05-20

Improving Coronary Vascular Health in WomenNCT06843902 · lead sponsor · 2025-04-17

TMS for Cognitive Decline in Aging and Preclinical ADNCT06956300 · lead sponsor · 2025-04-07

PrEP My Way: A Hybrid Type 1 Clinical Effectiveness-implementation Trial to Promote PrEP Persistence Among Young Kenyan WomenNCT06566430 · lead sponsor · 2025-03-03

A Preventive Behavioral Intervention for Young Adults With Psychotic ExperiencesNCT06929442 · lead sponsor · 2025-02-10

The Effects of Auditory Stimulation During Sleep on Brain Networks in SchizophreniaNCT06386588 · lead sponsor · 2025-02-05

Individual Closed-Loop Neuromodulation Therapy for Alzheimer's DiseaseNCT05904132 · lead sponsor · 2025-01-31

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via InfliximabNCT06136546 · lead sponsor · 2025-01-23

Adaptation of an Intervention Addressing Barriers to PrEP Use Among Pregnant Women in ZimbabweNCT06226155 · lead sponsor · 2024-10-21

Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung CancerNCT06427954 · lead sponsor · 2024-08-06

Comparative-effectiveness of a Healthy Lifestyle and Asthma Management Program, In-person vs. ONlineNCT06432790 · lead sponsor · 2024-07-17

Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People at Risk for Alzheimer's DiseaseNCT05776641 · lead sponsor · 2024-06-21

ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIVNCT06274632 · lead sponsor · 2024-05-22

PET Imaging Evaluation of [11C]SY08NCT06098612 · lead sponsor · 2024-05-01

The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)NCT06412172 · lead sponsor · 2024-04-15

Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental IllnessNCT05962879 · lead sponsor · 2024-03-22

South Africa Smoking Cessation and Engagement in HIV/TB Care CareNCT05842161 · lead sponsor · 2024-03-12

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGHNCT06003153 · lead sponsor · 2024-03-12

Targeting Specific Brain Networks to Treat Specific Symptoms in DepressionNCT05523817 · lead sponsor · 2024-03-12

A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan AfricaNCT05373758 · lead sponsor · 2024-02-07

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver CirrhosisNCT06265272 · lead sponsor · 2023-12-10

Patient-centered, Optimal Integration of Survivorship and Palliative CareNCT04900935 · lead sponsor · 2023-09-29

Lung Cancer Screening in High-risk Black IndividualsNCT05898594 · lead sponsor · 2023-09-06

Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical ADNCT05881239 · lead sponsor · 2023-05-09

Transcranial Magnetic Stimulation Treatment for Alzheimer's DiseaseNCT06538311 · lead sponsor · 2023-05-01

Salivary Extracellular Vesicle Associated lncRNAs in Heart Failure (SEAL-HF)NCT06169540 · lead sponsor · 2023-04-19

Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income PopulationNCT05799222 · lead sponsor · 2023-03-28

Drugs studied in this sponsor's trials

177 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Massachusetts General Hospital as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

placebo74

carboplatin10

paclitaxel8

bevacizumab7

cyclophosphamide7

ketamine7

cisplatin6

cycloserine6

placebo RxCUI 8375 · Lead sponsor in 59 linked trial(s) · 3 currently recruiting 74 trials carboplatin RxCUI 40048 · Lead sponsor in 4 linked trial(s) · 1 currently recruiting 10 trials paclitaxel RxCUI 56946 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 8 trials bevacizumab RxCUI 253337 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 7 trials cyclophosphamide RxCUI 3002 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 7 trials ketamine RxCUI 6130 · Lead sponsor in 7 linked trial(s) · 1 currently recruiting 7 trials cisplatin RxCUI 2555 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting 6 trials cycloserine RxCUI 3007 · Lead sponsor in 6 linked trial(s) · 0 currently recruiting 6 trials escitalopram RxCUI 321988 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting 6 trials docetaxel RxCUI 72962 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 5 trials etanercept RxCUI 214555 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting 5 trials fulvestrant RxCUI 282357 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 5 trials metformin RxCUI 6809 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting 5 trials tesamorelin RxCUI 1044584 · Lead sponsor in 5 linked trial(s) · 1 currently recruiting 5 trials doxorubicin RxCUI 3639 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 4 trials erlotinib RxCUI 337525 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 4 trials Herceptin RxCUI 101306 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 4 trials pembrolizumab RxCUI 1547545 · Lead sponsor in 3 linked trial(s) · 2 currently recruiting 4 trials pemetrexed RxCUI 68446 · Lead sponsor in 3 linked trial(s) · 1 currently recruiting 4 trials somatropin RxCUI 61148 · Lead sponsor in 4 linked trial(s) · 0 currently recruiting 4 trials trastuzumab RxCUI 224905 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 4 trials varenicline RxCUI 591622 · Lead sponsor in 3 linked trial(s) · 1 currently recruiting 4 trials aripiprazole RxCUI 89013 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials cabozantinib RxCUI 1363268 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials

Sponsor roles

lead sponsor688

collaborator220

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.